Swissmedic: New Technical Interpretation on the Return of Medicinal Products
Swissmedic has published a new Technical Interpretation based on the guidelines of Good Distribution Practice (GDP). It defines the minimum requirements for wholesalers handling medicinal products returned by retailers, particularly with regard to the time limits that must be observed between delivery and return of the medicinal products.
In the past, Swissmedic addressed the handling of returns in connection with the authorisation requirement in Swissmedic Journal 05/2010. The content of this Swissmedic Journal publication (05/2010) is no longer valid, as it was rendered obsolete by the entry into force of the EU GDP guidelines (2013/C 343/01) and the comprehensive revision of the MPLO (Medicinal Products Licensing Ordinance) in 2019.
Source:
Swissmedic: General publications - New technical interpretation: I-SMI.TI.28 Returns of medicinal products
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
